LUTALYSE HC DIN 02460394
Status: Approved
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | DINOPROST (DINOPROST TROMETHAMINE) 12.5 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intramuscular; Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | |
|---|
| Current status date | 13-Jan-2017 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DINOPROST (DINOPROST TROMETHAMINE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02468697 | ENZAPROST T | CEVA ANIMAL HEALTH INC | Solution | DINOPROST (DINOPROST TROMETHAMINE) 5 MG | Marketed |
| 00813605 | LUTALYSE | ZOETIS CANADA INC | Solution | DINOPROST (DINOPROST TROMETHAMINE) 5 MG | Marketed |
| 00318736 | PROSTIN F2 ALPHA | PFIZER CANADA ULC | Solution | DINOPROST (DINOPROST TROMETHAMINE) 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 18852 | 2017-01-13 | Supplement to a New Drug Submission (SNDS) | ADDITONAL STRENGTH, ADDITIONAL ROUTE (SUBCUTANEOUS) |
Request a quote for LUTALYSE HC
How to read a Canadian DIN record